Although the tumor heterogeneity could have played a role in the lack of FAT1 and TERT promoter mutations in the primary tumor; similar allele frequency with the TP53 mutation in both samples suggests the same clone with the primary tumor. This evidence concerns the gene TP53 and neoplasm.